Savara Inc. Files DEF 14A for 2024 Executive Compensation
Ticker: SVRA · Form: DEF 14A · Filed: Apr 25, 2025 · CIK: 1160308
| Field | Detail |
|---|---|
| Company | Savara Inc (SVRA) |
| Form Type | DEF 14A |
| Filed Date | Apr 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
Related Tickers: SAR
TL;DR
Savara (SAR) DEF 14A out: exec comp details for 2024. Governance focus.
AI Summary
Savara Inc. (SAR) filed a DEF 14A on April 25, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other corporate governance matters. The company, formerly known as Mast Therapeutics, Inc., is based in Austin, TX, and operates in the pharmaceutical preparations industry.
Why It Matters
This filing provides shareholders with crucial information regarding how executive compensation is structured and approved, impacting corporate governance and investor confidence.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing detailing executive compensation and corporate governance, not indicating immediate operational or financial risk.
Key Numbers
- 20250425 — Filing Date (Date the DEF 14A was filed.)
- 20250605 — Period of Report (The period covered by the filing.)
- 2024-12-31 — Fiscal Year End (The end date of the company's fiscal year.)
Key Players & Entities
- Savara Inc. (company) — Filer
- Mast Therapeutics, Inc. (company) — Former Company Name
- ADVENTRX PHARMACEUTICALS INC (company) — Former Company Name
- BIOKEYS PHARMACEUTICALS INC (company) — Former Company Name
- 0001193125-25-096895 (dollar_amount) — Accession Number
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is used to solicit shareholder votes on important corporate matters, such as the election of directors and executive compensation.
When was Savara Inc. formerly known as Mast Therapeutics, Inc.?
Savara Inc. was formerly known as Mast Therapeutics, Inc. after a date of name change on 20130312.
What is Savara Inc.'s Standard Industrial Classification (SIC) code?
Savara Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Savara Inc. headquartered?
Savara Inc. is headquartered in Austin, TX, with its business and mailing address at 6836 Bee Cave Road, Building 3, Suite 201, Austin, TX 78746.
What is the filing date of this DEF 14A for Savara Inc.?
The DEF 14A filing for Savara Inc. was filed on April 25, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 25, 2025 regarding Savara Inc (SVRA).